Covered recipient · General Payments record
LINDSAY P HOUGHTON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,396.33
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $365.23 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $85.32 | 4 |
| ABBVIE INC. | $68.91 | 3 |
| Corium, Inc. | $46.98 | 2 |
| IRONSHORE PHARMACEUTICALS INC. | $39.95 | 2 |
| Merck Sharp & Dohme Corporation | $34.37 | 1 |
| Lilly USA, LLC | $32.13 | 2 |
| Xeris Pharmaceuticals, Inc. | $23.57 | 1 |
| Phadia US Inc. | $18.08 | 1 |
| GlaxoSmithKline, LLC. | $15.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.55 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359885 | CMS |
| ABBVIE INC. | $13.13 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359887 | CMS |
| ABBVIE INC. | $22.23 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107359889 | CMS |
| Corium, LLC | $24.78 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100191081 | CMS |
| Corium, LLC | $22.20 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100184267 | CMS |
| GlaxoSmithKline, LLC. | $15.92 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116260456 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $19.97 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146285580 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $19.98 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146285732 | CMS |
| Lilly USA, LLC | $14.11 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135799366 | CMS |
| Lilly USA, LLC | $18.02 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135752893 | CMS |
| Merck Sharp & Dohme LLC | $34.37 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141947595 | CMS |
| Novo Nordisk Inc | $19.98 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100239064 | CMS |
| Novo Nordisk Inc | $20.84 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100318332 | CMS |
| Novo Nordisk Inc | $21.99 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100384359 | CMS |
| Novo Nordisk Inc | $22.51 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100484257 | CMS |
| Phadia US Inc. | $18.08 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067582348 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.57 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144633067 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.